Simplex Trading’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$738 Sell
300
-37,500
-99% -$126K ﹤0.01% 8666
2025
Q4
$150K Buy
37,800
+100
+0.3% +$443 ﹤0.01% 4524
2025
Q3
$10K Buy
+37,700
New +$128K ﹤0.01% 7893
2023
Q4
Sell
-800
Closed -$1K 9282
2023
Q3
$1K Buy
+800
New +$1.76K ﹤0.01% 8326
2022
Q3
Sell
-2,300
Closed -$25K 10352
2022
Q2
$25K Buy
2,300
+1,900
+475% +$22.8K ﹤0.01% 7336
2022
Q1
$6K Buy
400
+200
+100% +$5.13K ﹤0.01% 9286
2021
Q4
$9K Sell
200
-1,300
-87% -$78K ﹤0.01% 9118
2021
Q3
$126K Hold
1,500
﹤0.01% 6286
2021
Q2
$125K Buy
1,500
+1,497
+49,900% +$98.8K ﹤0.01% 6407
2021
Q1
$14K Buy
+3
New +$163 ﹤0.01% 7701

Other funds holding NBP

Simplex Trading's NBP Position: Q1 2026 in Review

Simplex Trading sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 3,060 shares — an estimated $10.2K sold.

Simplex Trading first reported a position in NBP in Q1 2021 and held it in 16 quarters. The position peaked at $40K in Q4 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Simplex Trading reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,060 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $10.2K.
  • Simplex Trading first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 16 quarters.
  • Simplex Trading's NovaBridge Biosciences American Depositary Shares position peaked at $40K in Q4 2022.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.